CLGN – collplant biotechnologies ltd. - ordinary shares (US:NASDAQ)
Stock Stats
News
CollPlant Biotechnologies (NASDAQ:CLGN) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $12.00 price target on the stock.
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE [Yahoo! Finance]
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS
CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada
Form SCHEDULE 13D/A CollPlant Biotechnologie Filed by: Sagy Ami
Form 6-K CollPlant Biotechnologie For: Nov 26
Form 6-K CollPlant Biotechnologie For: Nov 26
Form SCHEDULE 13D/A CollPlant Biotechnologie Filed by: Loewenbaum Lilian S.
Form 6-K CollPlant Biotechnologie For: Oct 27
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.